Cytokine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated autoantibodies

被引:41
作者
Halminen, M
Simell, O
Knip, M
Ilonen, J
机构
[1] Univ Turku, Dept Virol, FIN-20520 Turku, Finland
[2] Univ Turku, JDFI Ctr Diabet Prevent Finland, FIN-20520 Turku, Finland
[3] Univ Turku, Dept Paediat, FIN-20520 Turku, Finland
[4] Univ Tampere, Sch Med, Dept Paediat, FIN-33101 Tampere, Finland
关键词
D O I
10.1046/j.1365-3083.2001.00904.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The aim of this study was to evaluate possible changes in the circulating levels of interferon (IFN)-gamma, interleukin (IL)-4 and transforming growth factor (TGF)-beta in association with the autoimmune process leading to type 1 diabetes, Expression levels of mRNAs specific for each cytokine were determined in peripheral blood mononuclear cells (PBMC) by a multiplex reverse transcription-polymerase chain reaction (RT-PCR) followed by hybridization reactions with lanthanide-labelled probes and detection by time-resolved fluorometry. Newly diagnosed diabetic children had lower levels of IFN-gamma, IL-4 and TGF-beta1 signals compared to their age- and sex-matched controls (P < 0.02, P < 0.005 and P < 0.005, respectively) and also the autoantibody-positive subjects had significantly lower levels of IL-4 and TGF-<beta>1 in comparison with their matched controls (P = 0.0013 and P = 0.012). No significant differences were observed when comparing matched pairs of diabetic children and autoantibody-positive subjects. Our results suggest a systemic bias towards reduced production of T-helper cell type 2 cytokines (IL-4 and TGF-beta1) during the autoimmune process, but there was also a reduced level of IFN-gamma expression in the periphery at the onset of clinical diabetes.
引用
收藏
页码:510 / 513
页数:4
相关论文
共 25 条
[1]
Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]
ALKASSAB AS, 1990, CLIN EXP IMMUNOL, V81, P267
[3]
INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[4]
INSULIN-DEPENDENT DIABETES-MELLITUS AS A BETA-CELL TARGETED DISEASE OF IMMUNOREGULATION [J].
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) :439-463
[5]
Transforming growth factor β1 (TGFβ1) mRNA level correlates with magnetic resonance imaging disease activity in Multiple Sclerosis patients [J].
Bertolotto, A ;
Capobianco, M ;
Malucchi, S ;
Manzardo, E ;
Audano, L ;
Bergui, M ;
Bradac, GB ;
Mutani, R .
NEUROSCIENCE LETTERS, 1999, 263 (01) :21-24
[6]
ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES [J].
BOTTAZZO, GF ;
FLORINCH.A ;
DONIACH, D .
LANCET, 1974, 2 (7892) :1279-1283
[7]
CAVALLO MG, 1991, CLIN EXP IMMUNOL, V86, P256
[8]
Transforming growth factor-beta (TGF-β) [J].
Clark, DA ;
Coker, R .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1998, 30 (03) :293-298
[9]
INSULITIS IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN MAN - MACROPHAGES, LYMPHOCYTES, AND INTERFERON-GAMMA CONTAINING CELLS [J].
FOULIS, AK ;
MCGILL, M ;
FARQUHARSON, MA .
JOURNAL OF PATHOLOGY, 1991, 165 (02) :97-103
[10]
Simultaneous detection of IFN-γ and IL-4 mRNAS using RT-PCR and time-resolved fluorometry [J].
Halminen, M ;
Sjöroos, M ;
Mäkelä, MJ ;
Waris, M ;
Terho, E ;
Lövgren, T ;
Ilonen, J .
CYTOKINE, 1999, 11 (01) :87-93